Streetbeat News

Earnings

TSLA

Tesla Inc. (NASDAQ:TSLA) aims to produce 2.77 million vehicles by 2025, a 50% increase from 2023, including new affordable models. Analyst Gary Black suggests the market underestimates Tesla's expansion into the $30,000 segment. Tesla's current capacity is 2.35 million units, with a potential maximum of 3 million. Despite recent earnings scrutiny, Tesla's resilience is noted.

Portfolio Pulse from Benzinga Neuro

July 29, 2024 | 3:36 am

AAPL

MSFT

Leading cryptocurrencies like Bitcoin and Ethereum held their gains as Donald Trump made pro-crypto promises. Bitcoin nearly touched $69,000, and Ethereum retraced to $3,270. Futures Open Interest for both increased, signaling a potential upside breakout. Stock market futures also edged higher, with Microsoft and Apple set to report earnings. The Federal Reserve will hold an FOMC meeting this week.

Portfolio Pulse from Aniket Verma

July 29, 2024 | 2:30 am

AAPL

CRWD

META

NVDA

RBLX

TXN

WBD

The past week in consumer tech saw significant developments including a global tech outage caused by a flawed update from CrowdStrike Holdings Inc. (CRWD), leading to widespread criticism. Roblox Corporation (RBLX) reported a sharp increase in child exploitation incidents. Apple Inc. (AAPL) and Texas Instruments (TXN) both reported earnings that beat analyst estimates. Nvidia Corp. (NVDA) is developing a new AI chip for the Chinese market and has approved the use of Samsung's HBM3 chips. Meta Platforms Inc. (META) faces scrutiny from the EU over its 'pay or consent' model. Warner Bros. Discovery, Inc. (WBD) announced the acquisition of Player First Games.

Portfolio Pulse from Lekha Gupta

July 28, 2024 | 7:39 pm

DELL

EW

F

LKQ

MBLY

SMCI

STLA

STM

TER

UPS

VRT

WST

The article highlights the top 12 large-cap stock losers from July 21 to July 27, including Ford, Stellantis, and Dell. Key reasons for the declines include earnings misses, lowered guidance, and broader market selloffs.

Portfolio Pulse from Lekha Gupta

July 28, 2024 | 5:58 pm

AVTR

CBRE

DHR

FCNCA

LMT

MANH

MOH

QXO

THC

TMO

UHS

Eleven large-cap stocks performed exceptionally well last week, with notable gains driven by positive earnings reports, guidance increases, and other favorable news. Key performers include QXO, Inc., Avantor Inc, Universal Health Services, Inc., Manhattan Associates Inc, Molina Healthcare Inc, First Citizens BancShares, Inc., Tenet Healthcare Corporation, CBRE Group Inc, Thermo Fisher Scientific Inc, Danaher Corp, and Lockheed Martin Corporation.

Portfolio Pulse from Lekha Gupta

July 28, 2024 | 5:28 pm

AMC

GOOG

META

TSLA

Benzinga reviewed the performance of popular stocks and economic indicators over the past week. The S&P 500 and Nasdaq experienced losses, while the Dow and Russell 2000 saw gains. Key economic data showed stronger-than-expected growth and lower inflation, raising hopes for interest rate cuts. The article highlighted bullish and bearish stock analyses, including AMC's debt restructuring, Tesla's innovation-driven growth, and concerns over Alphabet's AI investments.

Portfolio Pulse from Michael Cohen

July 27, 2024 | 3:59 pm

GM

KARS

LCID

RIVN

TSLA

XIACY

This week saw significant developments in the EV sector, with Tesla's mixed earnings report leading to a stock drop, Rivian's CEO discussing the new R2 platform, GM scaling back its EV goals, Xiaomi ramping up EV production, and Lucid securing a battery material deal. The KraneShares Electric Vehicles and Future Mobility Index ETF also saw a decline.

Portfolio Pulse from Shanthi Rexaline

July 27, 2024 | 3:43 pm

PBYI

Puma Biotechnology (NASDAQ:PBYI) has received consistent 'Buy' ratings from analysts at HC Wainwright & Co. over the past three months, with a stable 12-month price target of $7.00. Despite facing revenue challenges and a high debt-to-equity ratio, the company shows strong net margin, ROE, and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 9:01 pm

BWMX

Betterware de Mexico SAPI (NYSE:BWMX) has received 7 bullish ratings from analysts in the past three months, with a consistent 12-month price target of $22.50. The company shows strong revenue growth and net margins but has a lower ROE compared to industry standards.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 9:00 pm

FCAP

First Cap (NASDAQ:FCAP) reported a 3.66% increase in Q2 earnings per share (EPS), rising from $0.82 to $0.85 year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:46 pm